Corient Private Wealth’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,096
Closed -$2.76M 3061
2026
Q1
$2.76M Sell
37,096
-99,342
-73% -$7.47M ﹤0.01% 1097
2025
Q4
$9.68M Buy
136,438
+83,892
+160% +$6.13M 0.01% 788
2025
Q3
$3.55M Sell
52,546
-161
-0.3% -$10.7K 0.01% 838
2025
Q2
$3.43M Buy
52,707
+6,432
+14% +$386K ﹤0.01% 828
2025
Q1
$2.86M Sell
46,275
-7,031
-13% -$466K ﹤0.01% 852
2024
Q4
$3.84M Buy
53,306
+1,518
+3% +$119K 0.01% 776
2024
Q3
$4.22M Buy
51,788
+1,856
+4% +$148K 0.01% 801
2024
Q2
$3.71M Sell
49,932
-3,051
-6% -$229K 0.01% 795
2024
Q1
$4.13M Buy
52,983
+1,877
+4% +$140K 0.01% 761
2023
Q4
$3.65M Buy
51,106
+36,550
+251% +$2.54M 0.01% 788
2023
Q3
$1.01M Buy
14,556
+701
+5% +$53K ﹤0.01% 1182
2023
Q2
$1.12M Sell
13,855
-116
-0.8% -$9.48K ﹤0.01% 1107
2023
Q1
$1.13M Buy
13,971
+6,423
+85% +$517K ﹤0.01% 1038
2022
Q4
$565K Buy
+7,548
New +$538K ﹤0.01% 1104

Other funds holding HOLX

Corient Private Wealth's HOLX Position: Q2 2026 in Review

Corient Private Wealth sold out of Hologic (HOLX) in Q2 2026, closing a stake of 37,096 shares — an estimated $2.76M sold.

Corient Private Wealth first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $9.68M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Corient Private Wealth reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Corient Private Wealth sold 37,096 Hologic shares in Q2 2026, an estimated $2.76M.
  • Corient Private Wealth first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • Corient Private Wealth's Hologic position peaked at $9.68M in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.